COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,844 Articles (22,553 medRxiv, 8,291 bioRxiv)

Most recent first Previous |  Page 304: Articles 3031-3040  | Next

Compartmentalized SARS-CoV-2 replication in upper versus lower respiratory tract after intranasal inoculation or aerosol exposure
Fischer, R., Bushmaker, T., Williamson, B. N., Perez-Perez, L., Feldmann, F., Lovaglio, J., Scott, D., Saturday, G., Feldmann, H., Munster, V. J., de Wit, E., van Doremalen, N.
10.1101/2023.09.11.557190 — Posted: 2023-09-12
Dual inhibition of coronavirus Mpro and PLpro enzymes by phenothiazines and their antiviral activity
Forrestall, K. L., Pringle, E. S., Sands, D., Duguay, B., Farewell, B., Woldemariam, T., Falzarano, D., Pottie, I. R., McCormick, C., Darvesh, S.
10.1101/2023.09.11.557219 — Posted: 2023-09-12
Concurrent administration of COVID-19 and influenza vaccines enhances Spike-specific antibody responses
Barouch, S. E., Chicz, T. M., Blanc, R., Barbati, D. R., Parker, L. J., Tong, X., McNamara, R. P.
10.1101/2023.09.12.557347 — Posted: 2023-09-12
Comparative Analysis of Association Networks Using Single-Cell RNA Sequencing Data Reveals Perturbation-Relevant Gene Signatures
Nouri, N., Gaglia, G., Mattoo, H., de Rinaldis, E., Savova, V.
10.1101/2023.09.11.556872 — Posted: 2023-09-12
Expression Level Analysis of ACE2 Receptor Gene in African-American and Non-African-American COVID-19 Patients
Nyamari, M. N., Omar, K. M., Fayehun, A. F., Dachi, O., Bwana, B. K., Awe, O. I.
10.1101/2023.09.11.557129 — Posted: 2023-09-12
Deep mutational scans of XBB.1.5 and BQ.1.1 reveal ongoing epistatic drift during SARS-CoV-2 evolution
Taylor, A. L., Starr, T. N.
10.1101/2023.09.11.557279 — Posted: 2023-09-12
Risk of Ischemic Stroke after COVID-19 Bivalent Booster Vaccination in an Integrated Health System
Sharff, K., Tandy, T. K., Lewis, P. F., Johnson, E. S.
10.1101/2023.09.11.23295368 — Posted: 2023-09-12
SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients
Chen, Y., Zhao, T., Chen, L., Jiang, G., Geng, Y., Li, W., Yin, S., Tong, X., Tao, Y., Ni, J., Lu, Q., Ning, M., Wu, C.
10.1101/2023.09.08.556870 — Posted: 2023-09-12
Comparison of COVID-19 and Influenza-Related Outcomes in the United States during Fall-Winter 2022-2023
Kopel, H., Bogdanov, A., Winer-Jones, J., Adams, C., Winer, I., Bonafede, M., Nguyen, V. H., Mansi, J. A.
10.1101/2023.09.08.23295262 — Posted: 2023-09-11
A Bayesian approach to identifying the role of hospital structure and staff interactions in nosocomial transmission of SARS-CoV-2
Bridgen, J. R. E., Lewis, J. M., Todd, S., Taegtmeyer, M., Read, J. M., Jewell, C. P.
10.1101/2023.09.11.23295353 — Posted: 2023-09-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).